Teladoc Health, Inc.
$1.40B- Market cap
- $1.14B
- Debt
- +$1.04B
- Cash
- −$781.08M
Capital structure 52% equity / 48% debt · EV / Revenue 0.55x · EV / EBITDA 4.74x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt cap
Decision snapshot: TDOC stock price at discount vs HSY $6.28 current versus $41.83 implied using P/S multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at HSY's multiple
Implied fair value · at TDOC's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Multiple discount
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: TDOC FY 2025 (ended Dec 31, 2025) · HSY FY 2025 (ended Dec 31, 2025).
Trendline
Ten fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 52% equity / 48% debt · EV / Revenue 0.55x · EV / EBITDA 4.74x
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 87% equity / 13% debt
HSY carries the larger enterprise value at $40.31B against $1.40B; TDOC trades on the lower EV / Revenue multiple (0.55x vs 3.45x); TDOC on the lower EV / EBITDA (4.74x vs 19.67x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
TELADOC HEALTH, INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
HERSHEY CO · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.75x
1.12x
Net debt / EBITDA
Leverage against operating earnings
0.87x
—
Cash and equivalents
Liquid reserves on the balance sheet
$781.08M
—
Total debt
Interest-bearing obligations outstanding
$1.04B
$5.18B
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Hims & Hers Health, Inc.
TDOC vs HIMS
GoodRx Holdings, Inc.
TDOC vs GDRX
Cigna Group
TDOC vs CI
VEEVA SYSTEMS INC
TDOC vs VEEV
Mondelez International, Inc.
TDOC vs MDLZ
PEPSICO INC
TDOC vs PEP
GENERAL MILLS INC
TDOC vs GIS
KELLANOVA
TDOC vs K
COCA COLA CO
TDOC vs KO
FLOWERS FOODS INC
TDOC vs FLO
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.